Concepedia

Lutz Wollin

LW

40

Publications

3K

Citations

26

H-Index

1994

Active since

Affiliations

Boehringer Ingelheim (Germany)(Current)

Inserm

University of Konstanz

Université de Rennes

Centre Hospitalier Universitaire de Rennes

Lutz Wollin is an author at Boehringer Ingelheim (Germany) specializing in medicine, pharmacology, and inflammation.

ORCID

Top concepts

Publications per year

1994–2024

40

Publications

40

Antifibrotic and Anti-inflammatory Activity of the Tyrosine Kinase Inhibitor Nintedanib in Experimental Models of Lung Fibrosis

Lutz Wollin, Isabelle Maillet, Valérie Quesniaux et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 610 citations

In Vivo Efficacy in Airway Disease Models of Roflumilast, a Novel Orally Active PDE4 Inhibitor

Daniela S. Bundschuh, Manfrid Eltze, Johannes Barsig et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 237 citations

Roflumilast Fully Prevents Emphysema in Mice Chronically Exposed to Cigarette Smoke

Piero A. Martorana, Rolf Beume, Monica Lucattelli et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 192 citations

Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis

Jingang Huang, Christian Beyer, Katrin Palumbo‐Zerr et al. · Annals of the Rheumatic Diseases · 2015 · 189 citations

Nintedanib inhibits macrophage activation and ameliorates vascular and fibrotic manifestations in the Fra2 mouse model of systemic sclerosis

Jingang Huang, Christiane Maier, Yun Zhang et al. · Annals of the Rheumatic Diseases · 2017 · 181 citations

Rows per page

1–5 of 40